Results 221 to 230 of about 34,166 (308)
The efficacy of Shenyankangfu tablets in combination with valsartan in diabetic nephropathy: A systematic review and meta-analysis. [PDF]
Yang Y +6 more
europepmc +1 more source
Our study investigates the relationship between hepatic fibrosis and femoral neck bone mineral density (BMD) in MAFLD patients with type 2 diabetes mellitus (T2DM‐MAFLD) and assesses the potential influence of metabolic factors. We found a non‐linear relationship between hepatic fibrosis and femoral neck BMD, particularly evident in postmenopausal ...
Jie Tao +3 more
wiley +1 more source
Non-Pharmacological Interventions Aimed at Changing the Gut Microbiota for Preventing the Progression of Diabetic Kidney Disease. [PDF]
Szczuko M +6 more
europepmc +1 more source
ABSTRACT Introduction Gestational diabetes mellitus (GDM) represents one of the most prevalent medical complications during pregnancy. Emerging evidence has implicated NOL1/NOP2/SUN domain (NSUN)2‐mediated 5‐methylcytosine (m5C) methylation modifications in various pathological conditions. This study aimed to investigate the role of m5C modification in
Jiujiu Liu +3 more
wiley +1 more source
Altered thiol/disulfide homeostasis in patients with diabetes mellitus and its chronic complications. [PDF]
Aslanoğlu N +3 more
europepmc +1 more source
Automated insulin delivery in people with type 1 diabetes and kidney failure on hemodialysis. ABSTRACT Diabetes management in end‐stage kidney disease (ESKD) is complicated by altered insulin pharmacokinetics and glucose metabolism, particularly in the context of hemodialysis (HD).
Panagiotis Pavlou +9 more
wiley +1 more source
Diabetic nephropathy with minimal change disease: a case report. [PDF]
Miao P, Mo X, Zhang X, Zhang M.
europepmc +1 more source
Overview of this research and pathological hypothesis. ABSTRACT Aims/Introduction Red blood cell distribution width (RDW) is a parameter of erythrocyte volume heterogeneity that has been traditionally used as an indicator of anemia and other hematopoietic abnormalities.
Kohsuke Miyataka +17 more
wiley +1 more source
Nomenclature of renal involvement in diabetes mellitus: unify to manage diversity. [PDF]
Marques M +4 more
europepmc +1 more source

